Live: Will FedEx Crush Q4 Earnings Tonight After the Market Closes?

Investing

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

253 Articles

Trey Thoelcke | Apr 9, 2014 at 8:45 AM EDT

These Top Stocks Are Cheap After Huge Market Sell-Off

ThinkstockIn just a matter of days, the S&P 500 managed to produce a sell-off of more than 6%. The equity…

Trey Thoelcke | Mar 11, 2014 at 8:45 AM EDT

Catalysts That Could Push Top Biotech Stocks Even Higher

Many bears on Wall Street say that biotech stocks are overvalued, but many trade in line with historical valuations. In…

Trey Thoelcke | Jan 29, 2014 at 8:15 AM EST

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

Like many firms on Wall Street, the biotechnology team at UBS thinks that most of the top mega-cap and large…

Jon C. Ogg | Jan 14, 2014 at 8:15 AM EST

UBS Has Nine Biotech Buyout and Merger Candidates

The analysts at UBS are not only bullish on the biotechnology sector, they think there is a very distinct possibility…

Jon C. Ogg | Jan 8, 2014 at 8:10 AM EST

J.P. Morgan Top Biotechnology Stocks to Buy for 2014

Biotechnology was an incredible performer in 2013. The analysts at J.P. Morgan think that the huge outperformance may lessen going…

Jon C. Ogg | Jan 6, 2014 at 9:00 AM EST

Ten Top Growth Stock Ideas for 2014 From Baird

Baird offers an eclectic and interesting list for investors. A top regional firm, it tends to dig a little deeper,…

Jon C. Ogg | Jan 6, 2014 at 8:45 AM EST

Top Analyst Upgrades and Stocks to Buy: AIG, Genworth, SolarCity and More

These are the top analyst upgrades, initiations and positive analyst research calls seen from Wall Street on Monday, January 6.

Trey Thoelcke | Dec 19, 2013 at 8:30 AM EST

Cowen Forecasts Top 10 Potential Biotech Surprises for 2014

The Cowen biotechnology team has a list of top 10 surprises that are specific to the very hot biotechnology sector.

Jon C. Ogg | Nov 2, 2013 at 7:15 AM EDT

Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex

ThinkstockIdenix Pharmaceuticals Inc. (NASDAQ: IDIX) was the biggest gainer of all listed stocks on Friday with a rally of 40%.…

Lee Jackson | Sep 4, 2013 at 8:25 AM EDT

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

ThinkstockEven though the equity strategy team at UBS has downgraded U.S. equities to Neutral from Outperform, they remain very positive…

Jon C. Ogg | Aug 22, 2013 at 8:40 AM EDT

Top Analyst Upgrades and Downgrades: Microsoft, Target, Zynga and More

Jon OggNow that stocks have pulled back and interest rates have risen, investors are looking for more guidance on which…

Jon C. Ogg | Jul 12, 2013 at 8:15 AM EDT

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

ThinkstockBiotechnology stocks have had an extremely solid first half of the year. The analysts at Cowen Group point out that…

Jon C. Ogg | Jul 2, 2013 at 8:45 AM EDT

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

ThinkstockOn Friday after the market closed, biotech giant Amgen Inc. (NASDAQ: AMGN) made an unsolicited $120 per share bid for…

Jon C. Ogg | Jun 13, 2013 at 8:15 AM EDT

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

ThinkstockThe higher the market climbs, the harder it becomes for investors to find solid stock ideas to add or scale…

Jon C. Ogg | May 29, 2013 at 8:40 AM EDT

Top Analyst Downgrades and Stocks to Sell: Comerica, Maxim and SeaWorld

These are the top analyst downgrades, cautious research notes and stocks to sell from Wall Street for Wednesday, May 29,…

1 … 10 11 12 13 14 … 17

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

These Top Stocks Are Cheap After Huge Market Sell-Off

Catalysts That Could Push Top Biotech Stocks Even Higher

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

UBS Has Nine Biotech Buyout and Merger Candidates

J.P. Morgan Top Biotechnology Stocks to Buy for 2014

Ten Top Growth Stock Ideas for 2014 From Baird

Top Analyst Upgrades and Stocks to Buy: AIG, Genworth, SolarCity and More

Cowen Forecasts Top 10 Potential Biotech Surprises for 2014

Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Top Analyst Upgrades and Downgrades: Microsoft, Target, Zynga and More

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

Top Analyst Downgrades and Stocks to Sell: Comerica, Maxim and SeaWorld

Live: Will FedEx Crush Q4 Earnings Tonight After the Market Closes?

Could You Afford To Retire In Elk Country On $300,000?

NVIDIA Is Stalled at $200. Is the Next Move a Breakout or a Breakdown?

Why 46% of Americans Are Leaving Thousands on the Table Annually

Could You Afford To Retire In Elk Country On $300,000?

Why 46% of Americans Are Leaving Thousands on the Table Annually

Could You Afford To Retire In Elk Country On $300,000?

NVIDIA Is Stalled at $200. Is the Next Move a Breakout or a Breakdown?

Vertex Pharmaceuticals : VRTX

All Vertex Pharmaceuticals Articles

These Top Stocks Are Cheap After Huge Market Sell-Off

Catalysts That Could Push Top Biotech Stocks Even Higher

UBS Says Buy Top Biotech Stocks in Front of Earnings for Big Upside

UBS Has Nine Biotech Buyout and Merger Candidates

J.P. Morgan Top Biotechnology Stocks to Buy for 2014

Ten Top Growth Stock Ideas for 2014 From Baird

Top Analyst Upgrades and Stocks to Buy: AIG, Genworth, SolarCity and More

Cowen Forecasts Top 10 Potential Biotech Surprises for 2014

Why Idenix Could Rise Even Higher, and Challenge Gilead and Vertex

UBS Picks Large Cap Biotechnology Stocks to Outperform the Rest of 2013

Top Analyst Upgrades and Downgrades: Microsoft, Target, Zynga and More

Cowen’s Eight Biotech Stocks to Buy That Could Beat Earnings: Alexion, Ariad and More

Which Biotech Stocks Are Buyout Targets After Onyx Pharmaceutical Rejects Amgen?

Merrill Lynch Top Biotechnology Stocks to Buy for Big Gains

Top Analyst Downgrades and Stocks to Sell: Comerica, Maxim and SeaWorld

Live: Will FedEx Crush Q4 Earnings Tonight After the Market Closes?

Could You Afford To Retire In Elk Country On $300,000?

NVIDIA Is Stalled at $200. Is the Next Move a Breakout or a Breakdown?

Why 46% of Americans Are Leaving Thousands on the Table Annually

Featured Reads

Could You Afford To Retire In Elk Country On $300,000?

Why 46% of Americans Are Leaving Thousands on the Table Annually